Research Centre for Topical Drug Delivery and Toxicology, Department of Pharmacy, University of Hertfordshire, College Lane Campus, Hatfield, AL10 9AB, UK.
MedPharm Ltd, 50 Occam Road, Surrey Research Park, Guildford, Surrey, GU2 7AB, UK.
Sci Rep. 2017 Aug 21;7(1):8999. doi: 10.1038/s41598-017-09014-6.
Metabolic imbalance in chronic diseases such as type-1 diabetes may lead to detectable perturbations in the molecular composition of residual skin surface components (RSSC). This study compared the accumulation rate and the composition of RSSC in type-1 diabetic patients with those in matched controls in order to identify potential biomarkers of the disease. Samples of RSSC were collected from the foreheads of type-1 diabetic (n = 55) and non-diabetic (n = 58) volunteers. Samples were subsequently analysed to identify individual components (sebomic analysis). There was no significant difference in the rate of accumulation of RSSC between type-1 diabetics and controls. In terms of molecular composition, 171 RSSC components were common to both groups, 27 were more common in non-diabetics and 18 were more common in type-1 diabetic patients. Statistically significant (P < 0.05) differences between diabetic and non-diabetic volunteers were observed in the recovered amounts of one diacylglyceride (m/z 594), six triacylglycerides (m/z 726-860) and six free fatty acids (m/z 271-345). These findings indicate that sebomic analysis can identify differences in the molecular composition of RSSC components between type-1 diabetic and non-diabetic individuals. Further work is required to determine the practical utility and identity of these potential biomarkers.
在 1 型糖尿病等慢性疾病中,代谢失衡可能导致残留皮肤表面成分 (RSSC) 的分子组成发生可检测到的变化。本研究比较了 1 型糖尿病患者和匹配对照者 RSSC 的积累速度和组成,以确定该疾病的潜在生物标志物。从 1 型糖尿病(n=55)和非糖尿病(n=58)志愿者的额头上采集 RSSC 样本。随后对样本进行分析以鉴定个体成分(皮脂分析)。1 型糖尿病患者和对照组 RSSC 的积累速度没有显著差异。就分子组成而言,两组共有 171 种 RSSC 成分,27 种在非糖尿病患者中更为常见,18 种在 1 型糖尿病患者中更为常见。在回收的一种二酰基甘油(m/z 594)、六种三酰基甘油(m/z 726-860)和六种游离脂肪酸(m/z 271-345)的量方面,糖尿病志愿者和非糖尿病志愿者之间存在统计学上显著的(P<0.05)差异。这些发现表明皮脂分析可以识别 1 型糖尿病患者和非糖尿病患者 RSSC 成分的分子组成差异。需要进一步的工作来确定这些潜在生物标志物的实际效用和身份。